Saturday, January 15, 2011

THE LONG TAIL OF GLOBAL HEALTH EQUITY

AMICOR COMMENT:

Progress and partial results in the diagnosis, treatment, prevention and rehabilitation of CVD are evident.
The identification of the classical risk factors for IHD, and the search for new candidate risk factors help to grade individually patients, to comprehend pathogeny, and the adoption of secondary prevention (when disease is already present) or primary prevention (when disease is not yet manifest).

Positive results are evident, but the persistence of inequalities (among people as well as among diseases) are evidences too, that much more can and must be done to reach the benefice to all.

Inequalities (in the incidence, in the precocity, severity, complications incidencde, and in our attitude face to distinct diseases) persist while we compare countries, subpopulations inside de same country and in a same city, among families, sexes and age groups.

While inequalities in health/disease are present we cannot consider accomplished our mission. It is necessary to follow searching for the causes of the inequity, and we need to be prepared to act in a more complete and adequate manner, searching for resources and partnership in science, techniques, arts, certainly yet available inside the human genius.

THE LONG TAIL OF GLOBAL HEALTH EQUITY


Posted on 12/27/10
2010-2011 is a key year for the global non-communicable disease movement, culminating in the September 2011 high-level United Nations meeting in New York City. Historically, non-communicable disease in middle-income countries has received close attention. In this moment, there is also a need to focus on the disease burden of the poorest populations, the bottom billion, largely composed of children and young adults.
"The Long Tail of Global Health Equity: Tackling the Endemic Non-Communicable Diseases of the Bottom Billion,"a conference hosted by Harvard Medical School, Partners In Health, Brigham and Women’s Hospital, NCD Alliance, and the Global Task Force on Expanded Access to Cancer Care & Control in Developing Countries will take place in March 2-3, 2011 in Boston at the Joseph P. Martin Conference Center on the Harvard Medical School campus. Attendance is free. 
The conference will bring together a select group of participants with expertise in conditions such as rheumatic heart disease, Burkitt’s lymphoma, malnutrition-associated diabetes, and the respiratory impact of household fuels, as well as experts in global health financing, infectious disease, and mental health. Some of the featured speakers will include Paul Farmer, Dean Jamison, K. Srinath Reddy, and Peter Hotez. The goal is to provide an opportunity to bring together leaders in the fight for global access to NCD care for the poorest populations. 

No comments:

Post a Comment